-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/obesity-child_research-protocol.pdf
March 31, 2010 - distinction between prevention (often called "intervention"
in the childhood obesity research field) and treatment … This review will focus on prevention; it
will not review the targeted treatment of overweight or obese … non-overweight children from becoming overweight or obese, while the primary
objective of obesity treatment … □ Studies that aim at weight loss (obesity treatment) will be excluded. … Thomson Medstat Research Brief: Childhood
Obesity: Costs, Treatment Patterns, Disparities
in Care
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/mmm-draft-protocol-amendment.pdf
February 02, 2022 - during referral
processes28, 29 or followup appointments (e.g., failed shared decision-making reduces treatment … congruent care,
e.g., providers not taking
cultural preferences or
differences into account in
treatment … in the served
community and outcomes
● Influence of racism on
quality of care
● Differential treatment … criminal justice
agencies before and after Medicaid expansion: A retrospective study of admissions to treatment … process assessment, health care"/
or outcome assessment, health care/ or patient outcome assessment/ or treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/home-based-care_research-protocol.pdf
November 19, 2014 - depression, delirium,
dementia with behavioral problems, pain
• Patient Safety
o Errors in diagnosis or treatment … , including medication errors
o Harms or unintended consequences of any procedures or treatments
provided … population,
setting, interventions, and comparison groups; a valid method for allocation of
patients to treatment … or identifying the treatment and control groups in observational
studies; low dropout rates and clear … designed to assess the comparative effectiveness and
harms by patient demographics, comorbidities, and treatment
-
effectivehealthcare.ahrq.gov/health-topics/oral-cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
March 01, 2012 - What other
medical, injury or treatment factors (i.e. orthopaedic
resident cases, time?) … Major bleeding occurred in
0.1% of patients in both treatment groups. … That treatment, as
with treatment for PE, usually with warfarin, carries with
it its own risks of bleeding … , FACS
Results If at all possible it would be helpful to show comparative
data in tables so that treatments … " may not provide a
complete picture of the effect of anticoagulation and
other treatments.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
January 01, 2011 - Accordingly, Medicare reimburses a major
share of total spending on cancer treatment, 45 percent of … marketplace.10 Further,
the development pipeline contains
numerous biologics that promise novel
anticancer therapies … The use of biologics in cancer therapy. US Pharmacist 2010;35(3)
(Oncology suppl):4-7.
10. … Novel agents on the horizon for cancer therapy.
CA Cancer J Clin 2009;59:111-137.
11. … Managing the expanded use of biologics across
therapeutic areas: an example from B-cell targeted therapies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/quality-gap-palliative-hospice_research-protocol.pdf
June 27, 2011 - and other interventions to treat pain are
supported by strong evidence,
3
and guideline-based pain treatments … improving pain management in cancer patients may not translate well to the frail
elderly, for whom the treatment … Evidence report on the treatment of pain in cancer patients. … When the treatment goal is not cure: are cancer patients equipped to
make informed decisions?
-
effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-38-chronic-conditions-comments.pdf
March 01, 2021 - Despite positive findings, the report assigns “Possible
positive effect(s)” to only four therapeutic … This lack of crucial information is a common problem in
medical device and therapeutic interventions … Section Comment Response
lengths to recommend
against the use of beta
blockers as first line
therapy … or therapies, even those
approved by FDA, that demonstrate long term health
outcomes. … used interchangeably
in the structured abstract, evidence summary, and
introduction) for device and therapy
-
effectivehealthcare.ahrq.gov/products/chronic-kidney-disease-anemia-2011/research-protocol
-
effectivehealthcare.ahrq.gov/products/hemorrhage-postpartum/research
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/obesity-research-methods_research-protocol.pdf
February 08, 2017 - This results in exposed and unexposed (or treatment and
control) groups that are nearly identical on … selection bias or endogeneity, a term used by
economists for treatment selection bias. … As mentioned above, experimental designs are able to achieve
balance between treatment and control groups … Behavioral treatment of obesity in patients
encountered in primary care settings: a
systematic review … status)
§ Geographical (e.g., zip code, census block)
§ Other patient specifications (e.g., diagnosis, treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-911-workforce-mental-health-disposition-comments.pdf
February 28, 2025 - as
well as the importance of decreasing stigma among this
population for receiving mental health treatment … explore in the discussion the role of job reporting
requirements for mental health issues and related treatment … and
any potential impact this might have on stigma or likelihood of
seeking treatment.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
January 01, 2024 - Intervention C Intervention C, Dose Received (Mean) Intervention D Intervention D, Dose Received (Mean) Treatment … Previous treatment with weak opioid: 42 vs. 38
Previous treatment with strong opioid: 19 vs. 11 96 71 … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-257-antenatal-care-evidence-summary.pdf
June 01, 2022 - improve the health and wellbeing of pregnant patients and their
babies through (1) medical screening and treatment … o Studies did not evaluate heterogeneity of treatment effects (whether some
specific groups of patients
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management_research-protocol.pdf
January 01, 2014 - developed a consensus definition of MTM as “a distinct service or group
of services that optimize therapeutic … the CMR as “a systematic process of collecting patient-specific information,
assessing medication therapies … designed to improve patients’ knowledge of their
prescriptions, over-the-counter medications, herbal therapies … substitution issue; complex regimen that can
be simplified with same therapeutic benefit; and potential … We will also consider
conducting mixed-treatment comparisons in a meta-analysis using Bayesian methods
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
October 01, 2010 - Food and Drug Administration has approved
rFVIIa for the treatment and prevention of bleeding in
patients
-
effectivehealthcare.ahrq.gov/sites/default/files/goldstrom.pdf
May 29, 2025 - So by youth-guided, we mean that youth are not only guiding their
treatment decisions, but they’re
-
effectivehealthcare.ahrq.gov/sites/default/files/politi.pdf
May 29, 2025 - Conversational Recommendations (3)
• Discuss how to determine whether there is any benefit
from treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research-2007.pdf
January 01, 2007 - Management (MTM)
programs, focused on optimizing therapeutic outcomes for patient with multiple
medications … benefit for Medicare beneficiaries (Part D).1 Included in
this act was a provision for optimizing therapeutic … Fatal adverse drug events: the paradox of drug
treatment. J Intern Med 2001;250(4):327-41.
19. … other prescribing physician when a
potential DTP exists and provision of recommended
alternative therapies … physician
prescribing pattern feedback, therapeutic guidelines,
and other tools designed to influence
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-rehospitalization_research.pdf
November 01, 2007 - geographically diverse sites within the HMO Research
Network Center for Education and Research on Therapeutics … As an observational study of treatment and outcomes in clinical practice, there is a
concern about treatment … vs. no treatment comparison. … with other
selected heart failure or cardiovascular therapies. … After accounting for
differences in characteristics and other treatments received between patients using